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SummAry – Surgical fistulas have been used to create dialysis access for over 50 years in chron-
ic kidney disease patients. however, due to problems like slow maturation and a high risk of throm-
bosis or stenosis, results remain sub-optimal with high intervention and surgery rates to maintain 
patency.
Endovascular methods for fistula creation were invented recently to resolve these issues, allowing 
haemodialysis patients to have an alternative non-surgical option, with two different devices currently 
available. Endovascular creation of A-v fistulas is involved with minimal vessel trauma, which could 
be the reason for encouraging initial results demonstrating high technical success rates, low interven-
tion rates, and good patient satisfaction. This article describes the technical aspects of these proce-
dures, patient selection as well as trial results, and the status of endovascular arteriovenous fistula 
creation.
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The prevalence of end-stage renal disease (ESrd) 
is still increasing in Europe, and vascular access is 
needed in most of these patients so that kidney func-
tion can be replaced by haemodialysis. At the same 
time, the number of kidney donors is still significantly 
lower in most countries than the growing incidence of 
end-stage renal disease (ESrd), despite efforts to in-
crease awareness for this issue1.
There are three available haemodialysis access mo-
dalities, which include arteriovenous fistula (Avf), 
arteriovenous fistula graft (AvG), and indwelling cen-
tral venous catheter (CvC). Among all these Avf is 
associated with the lowest mortality, morbidity, and 
cost2-4.
Brescia and Cimino first invented a surgical tech-
nique for Avf creation, which has set the base for 
thousands of procedures in the next 50 years and is the 
main option for dialysis access. Still, even with all ad-
vances in surgical methods, vascular access for haemo-
dialysis remains its weakest point as it is the leading 
cause of hospitalization in these patients5-7.
Avf formation is the currently recommended ac-
cess due to its proven lower mortality, morbidity, and 
cost compared with other solutions (8-10). however, 
between 20 and 60% of fistulas after surgical creation 
do not successfully mature or become unsuitable for 
haemodialysis. in the end, they become dependent on 
CvC, which is associated with higher morbidity 11.
Studies suggest that dialysis Avf usually requires 
up to 3 additional surgical or radiological interven-
tions to secure its usability. This, in addition to other 
mentioned problems, leads to lower patient satisfac-
tion and willingness to undergo such procedures 11-13.
despite modern surgery attempts to create the 
ideal Avf, creation, maturation, and duration remain 
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unpredictable and difficult. One of the important but 
underestimated issues with dialysis is the fact that of-
ten with patients with borderline end-stage renal dis-
ease, it is hard to predict when vascular access will be 
needed and when dialysis will be initiated. Evidence is 
lacking on when it is the optimal time to create fistu-
las, and the fistula first, Catheter last initiative rec-
ommends the formation of fistula 6 months prior to 
the expected dialysis (14). however, with the changing 
and unpredictable dynamics of renal disease, there can 
be disparities in the need for vascular access and Avf 
or graft formation, with up to 17% of patients never 
using their Avf due to slower progression to end-
stage renal disease, or up to 80% of patients still initi-
ating their dialysis with a CvC (15). Even though 
Avf remains the most often used vascular access with 
64% of patients using it, compared to 16.6% using 
grafts and 18.9% with CvC, the dialysis Access Con-
sortium data showed that up to 60% of Avfs are not 
suitable for dialysis at 6 months, which is either due to 
failure to mature initially or very often due to venous 
stenosis and thrombosis 16,17.
On the other hand, Av grafts and tunnelled cath-
eters can be placed and used quickly and used right 
away. however, both are connected to significant com-
plications like infection or thrombosis and show re-
duced durability compared to Avf.
it is believed that the mentioned problems with 
maturation and duration of surgical Avf occur due to 
specific changes that are present in the vascular biolo-
gy and vascular flow dynamics, which are still largely 
not understood. These processes include a reduction of 
luminal diameter due to neointimal hyperplasia and 
insufficient outward remodelling (18). most of the ef-
forts to advance in this area are focused on optimizing 
fistula maturation. Studies have shown that most fistu-
las have problems maturating due to neointimal hy-
perplasia at the juxta-anastomotic vein site, which is 
the result of endothelial and smooth-muscle injury 
from shear stress, turbulent flow, and tissue injury at 
the time of surgery (19). This process can trigger cer-
tain cellular and molecular mechanisms with the acti-
vation of myofibroblasts and fibroblasts within the 
endothelial wall, migrating from the media to the in-
tima along with local inflammation and oxidative 
stress 20.
Proper artery and vein selection can also be a factor 
causing inadequate Avf function, as the chosen ves-
sels can be of an inadequate size or positioned too 
deep. recommended vein diameter for Avf is 0.25cm 
and artery diameter of 0.2cm, with vessels superficial 
enough to be easily palpable after maturation21.
Except for the mentioned cellular mechanisms oc-
curring in neointimal hyperplasia, it is suspected that 
hemodynamic stress from turbulent vascular flow at 
the anastomosis site causes stenosis. furthermore, vas-
cular manipulation during the surgery itself is a very 
likely but underestimated cause of venous injury lead-
ing to stenosis and delayed maturation 22. The advances 
in vascular surgery over the past decades still have not 
been able to find an effective solution for this problem.
dialysis Av grafts, used more in some countries, 
also develop venous stenosis due to neointimal hyper-
plasia. The artificial graft material is also more suscep-
tible to thrombosis and infection, making the graft an 
inferior choice between these two surgical options.
for all these reasons, a demand was recognized for 
creating new vascular access creation options, which 
would be less invasive and possibly more durable than 
the established surgical methods. devices that have 
been tried out in the past showed limited success, but 
recently new technologies have demonstrated the po-
tential to change the conventional algorithm for dialy-
sis access. The endovascular approach has been used 
more often recently in various fields of medicine, 
thereby creating a less invasive option for some condi-
tions that were considered treatable only by surgery. 
This idea was also implemented in the arteriovenous 
access for renal disease. in the last two decades, endo-
vascular methods such as stenting for central venous 
stenosis and angioplasty for fistula maturation and 
proximal venous stenosis were increasingly used and 
now stand as the first therapy option for primary Av 
fistula pathology and insufficiency. The next step was 
creating an Avf using an endovascular approach as 
this may reduce vessel trauma and thereby reduce neo-
intimal hyperplasia leading to maturation failure. Also, 
the fact that endovascular procedures minimize pa-
tient discomfort and hospital stay present a benefit 
that can improve patient acceptance and fistula use.
Endovascular arteriovenous fistula creation  
for haemodialysis access
interventional radiologists performing haemodial-
ysis access interventions on a regular basis can find the 
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idea of percutaneous Avf creation as a potential fin-
ishing touch to the complete service that is provided to 
this group of patients. This idea has become a real op-
tion within the past years, and there are currently two 
devices being used with available results from multiple 
studies.
Both available options for percutaneous Avf cre-
ation are based on the same concept that vessels are 
not clamped, mobilized, dissected, or sutured. Both 
systems use heat in the form of radiofrequency to cre-
ate anastomosis. They create an anastomosis, which is 
located in the deep vascular system, between the artery 
and its two concomitant veins. This anastomosis is 
usually located in the proximal forearm, slightly distal 
to the perforating vein.
Both procedures require a detailed analysis of the 
vasculature before preparation and patient selection. 
The main decisive factor for percutaneous Avf cre-
ation is assessing the venous perforator close to the 
cubital fossa that connects the deep and superficial 
veins. The size of the vessels is also noted in the ex-
amination and, similar to the surgical approach, should 
include a 2 mm artery and vein, which should also 
have a straight parallel configuration for a good result. 
The perforating vein is sometimes difficult to analyse 
and find due to its frequent anatomical variations and 
duplications.
Percutaneous fistula is basically formed between 
the radial artery and vein or the ulnar artery and vein 
in the forearm near the cubital fossa, where the deep 
veins are connected to the superficial system through 
the perforator (23). The surgical procedure that some-
what resembles this concept is the Gracz fistula, in 
which the brachial artery is connected with the venous 
perforator 24.
Devices for AVF creation
There are currently 2 devices that have been certi-
fied by Conformité Européenne and approved by uS 
fdA to create an Avf through an endovascular ap-
proach: the everlinQ/WavelinQ endoAvf system 
(tvA medical, Becton dickenson and Company, 
franklin lakes, nJ) and the Ellipsys vascular System 
(Avenu medical, San Juan Capistrano, CA). An over-
view of the main characteristics of both systems is 
shown in table 1.
The everlinQ endoAvf system is based on two 
catheters that contain rare earth magnets at their tips. 
The first-generation device consisted of two 6 fr cath-
eters, which were inserted via the upper arm into the 
artery and accompanying vein. in 2017 a device with 
4 fr catheters has replaced the old 6 fr system in Eu-
rope, which allowed the use of radial or ulnar approach 
in most patients. One magnetic catheter is inserted 
into the ulnar or radial artery, while the other is in-
serted into the ulnar or radial deep vein with the help 
of ultrasound guidance. When the catheters are aligned 
with one another under fluoroscopic guidance, the 
magnets embedded within the catheters are attracted 
and aligned, simultaneously aligning a radiofrequency 
electrode in the venous catheter and a ceramic back-
stop in the arterial catheter. The heat created by the 
radiofrequency electrode, which is then released from 
the venous catheter, burns a channel for about 1-2 sec-
onds, creating a 5 mm × 1 mm side to side anastomosis 
between the artery and vein. The result is usually con-
firmed by angiography. A usual mild complication 
seen right after the creation is a vessel spasm triggered 
by thermal effects or electrical stimulation, but it usu-
ally resolves itself soon after the procedure. most pro-
cedures require additional coil embolization of the 
deep brachial vein proximal to the anastomosis and the 
perforating vein in order to increase the outflow into 
the superficial veins used for dialysis access. The proce-
dure is performed under light sedation with local an-
aesthesia administered at the puncture site.
The Ellipsys vascular Access System involves a 
thermal resistance anastomosis device (trAd) 25 that 
creates an Avf using a single 6 fr catheter that ther-
mally connects the vessels. One of the main differences 
to the previous device is that most procedures use ul-
trasound guidance alone without radiation exposure 
and contrast media. At the same time, this procedure 
requires the operator to have good ultrasound guid-
ance experience and skills in order to perform the pro-
cedure adequately. A puncture of a superficial vein (ce-
phalic or basilic) is made in the upper arm. from there, 
the device is navigated in retrograde fashion through 
the perforator to the deep venous system and then 
continues into the radial artery through its wall. A 
guidewire is then placed, and the Ellipsys device is in-
serted over it and advanced to the artery. The device 
catheter has two contact plates where one is placed in 
the vein and the other in the artery. radiofrequency is 
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used to create heat up to 15 seconds before the system 
is removed. Even though angiography is usually not 
needed to perform this procedure after the Avf cre-
ation, in most cases, an additional PtA is performed at 
the anastomosis site. After the Everlinq procedure, 
PtA is never recommended right after the procedure 
due to the fragility of the fresh anastomosis. Coiling of 
the deep vein system is performed only in exceptional 
cases and is usually not needed, like with the EverlinQ 
device.
Clinical results of the everlinq  
and ellipsys devices
The first trial evaluating the clinical results of the 
everlinQ endoAvf system was the flEX study.
This prospective study enrolled 33 patients and re-
ported a 97% technical success rate, 58 days to matura-
tion, and 96% of fistulas were considered mature and 
usable for dialysis after 3 months. technical success 
was achieved in 32 out of 33 cases (97.0%) 26.
The second important study that evaluated this sys-
tem in a multinational and multicentre trial was the 
novel endovascular access trial (nEAt), which in-
volved 80 patients who were treated using the 6fr sys-
tem. A high technical success rate of 98% was report-
ed. The endoAvf was considered physiologically suit-
able for dialysis within 3 months if brachial artery flow 
≥ 500ml/min and vein diameter ≥ 4mm. This was 
achieved in 87% of patients. reported 12-month pri-
mary and cumulative patencies were 69% and 84%, 
respectively, with 8% of patients experiencing serious 
adverse events 27. A single-centre observational study 
of WavelinQ for the 4f device with 12 months of fol-
low-up in 30 patients compared endovascular Av fis-
tulas with radiocephalic arteriovenous fistulas and 
found that primary patency at 6 and 12 months was 
greater in the WavelinQ group (65.5% at 6 months 
and 56.5% at 12 months) compared to the surgical 
group (53.4% at 6 months and 44% at 12 months) 
which would support that WavelinQ endovascular ar-
teriovenous fistulas may be considered as a first option 
in the access pathway particularly if vessels at the wrist 
are absent or less than ideal 28.
The EASE study reporting data from the newer 
4fr system is a multioperator, single-center, single-
Table 1. Percutaneous AVF creation systems characteristics, criteria and results 
Endovascular system EverlinQ Ellipsys








Perforating vein – radial A
Additional 
interventions
Coiling of the deep vein proximal to the 
anastomosis
PtA of the anastomosis










imaging guidance ultrasound for access
fluoroscopy for procedure




Presence of deep perforating vein
Brachial artery >2 mm, radial or ulnar artery  
>2 mm at the anastomosis and access
radial/ulnar/brachial vein >2 mm at the 
anastomosis and access
distance between proximal radial/ulnar artery  
and vein (anastomosis site) <1 mm
Presence of deep perforating vein
Perforator diameter >2 mm
Proximal radial artery lumen diameter 
>2 mm at the anastomosis
distance between the perforating vein 
and radial artery <1.5 mm
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arm, prospective study that included 32 patients with 
radial or ulnar access procedures. The technical success 
rate was 100% and primary and cumulative patency 
rates through 6 months were 83% and 87%.
The published results involving the Ellipsys device 
included 2 main studies. in the first study, 26 patients 
underwent creation of Avf, with a success rate of 88% 
(23 of 26 patients) 25. At 6 weeks, 87 % of the Avf 
were patent, and 80% were used for hd at 3 months. 
to improve the maturation of the shunts, 48% of the 
patients had to be treated with an additional PtA. 
however, in 87% of cases, additional procedures were 
needed, involving balloon dilation, vein embolization, 
vein ligation, venous transposition, and valvulotomy.
The second published report involved a multicentre 
uS study. it reported a technical success rate of 95.0% 
without reported serious adverse events. haemodialy-
sis could be achieved in 88.0% of the patients. This 
study also required significant additional interventions 
to enable maturation of the shunt, including 113 PtAs 
and 42 coil embolizations of the deep venous system.
A 2018 study showed results from 34 included pa-
tients, with similar results: a technical success of 96% 
and a cumulative patency rate of 92% (141 days aver-
age follow-up) 30.
A most recent single centre, single operator retro-
spective review of 100 patients treated with endovas-
cular Avf creation (65 Ellipsys and 35 WavelinQ pa-
tients) showed the technical success of the Ellipsys 
and WavelinQ to be 100% versus 97% with median 
procedure times of 14 versus 63 minutes. Successful 
pAvf dialysis was established in 31 of 39 patients 
(79.5%) versus 14 of 24 patients (58%), respectively. 
Secondary patency at 12 months was significantly 
higher among patients who had an Ellipsys procedure 
(82%) than among those who underwent the Wave-
linQ procedure (60%) 31.
Discussion
The usual order of preference for the dialysis access 
in end-stage renal disease patients involves the distal 
radial-cephalic fistula, a brachial-cephalic fistula, and a 
transposed brachial-basilic fistula, so the addition of a 
percutaneous approach to the proximal radial and ul-
nar Av fistulas presents 2 valuable new options with 
proximal vessel preservation. The endovascular fistula 
creation also has the benefit of avoiding a surgical pro-
cedure and with-it vessel manipulation, suturing, and 
trauma, all of which may contribute to the failure of 
Avf. Another potential benefit of the endoAvf over 
surgical Avf is the reduced need for interventions to 
mature access and maintain function. By contrast, the 
endoAvf procedure minimizes vessel trauma, poten-
tially lessening the stimulus for negative remodelling, 
leading to frequent reinterventions. The benefit of a 
lower intervention rate after percutaneous fistula cre-
ation has been explored by comparison with both pro-
pensity score-matched medicare and the united 
States renal data System cohorts of patients with 
surgical Avf 32. That comparison reported a signifi-
cantly lower rate of interventions and care costs within 
the first year of creation with endoAvf relative to sur-
gical Avf. Also, a reported lower re-intervention rate 
could lead to minimizing the mentioned surgical fa-
tigue cited by some patients as the reason to choose a 
central catheter over a surgical creation of a new fis-
tula. All these potential benefits of the endovascular 
approach to fistula creation position it in the same 
conversation with surgical techniques as a possible pri-
mary option to create functional vascular access.
Certain longstanding principles will still not be 
changed − those patients who are ideally suited for a 
surgical radiocephalic fistula will still be treated in the 
standard fashion. however, patients who are not can-
didates for a radiocephalic fistula, as well as patients 
with failed radiocephalic Avf, may find endovascular 
Avf creation to give them an option to receive a func-
tional Avf while preserving more central options for 
future access. The goal of these new minimally invasive 
procedures is not to completely replace surgical Avf 
but to provide a new anatomic location for Avf place-
ment with possibly less need for reintervention and 
earlier maturation.
Conclusion
haemodialysis access remains a complex problem 
for patients with end-stage renal disease. in recent 
years, two new devices for minimally invasive endovas-
cular fistula formation have been introduced to over-
come poor surgical Avf outcomes when it comes to 
maturation and need for reintervention and also to 
give patients additional anatomic locations.
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Sažetak
EndOvASKulArnO KrEirAnJE diJAliZnE ArtEriOvEnSKE fiStulE
L. Novosel, V. Vidjak i Dijana Zadravec
Kirurški napravljene fistule se koriste više od 50 godina za stvaranje pristupa za dijalizu kod pacijenata s kroničnim 
 bubrežnim zatajenjem. međutim, zbog problema kao što su dugotrajna maturacija te visok rizik tromboze ili stenose rezul-
tati ostaju suboptimalni s učestalim reintervencijama i operacijama kako bi se održala prohodnost fistule. Kako bi se premo-
stilo ove nedostatke od nedavno su stvorene endovaskularne metode za kreiranje fistula, što pacijentima na dijalizi daje 
 dodatnu nekiruršku opciju, s dva različita trenutno dostupna sustava.Endovaskularno kreiranje A-v fistule je povezano s 
minimalnom traumom krvnih žila što može biti razlog za ohrabrujuće rane rezultate, koji pokazuju visoku stopu tehničke 
uspješnosti, nisku stopu reintervencija uz dobro prihvaćanje od strane pacijenata.
u ovom radu opisujemo tehničke aspekte ovih zahvata, pravilan izbor pacijenata kao i rezultate istraživanja te trenutni 
status endovaskularnog zahvata stvaranja arteriovenske dijalizne fistule.
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